SIGMUND ROGICH - 20 Nov 2024 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
Director
Signature
/S/ SIGMUND ROGICH
Issuer symbol
BIVI
Transactions as of
20 Nov 2024
Net transactions value
$0
Form type
4
Filing time
07 Jan 2025, 17:26:37 UTC
Previous filing
06 Dec 2023
Next filing
09 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIVI Common Stock Award $0 +32,700 +774% $0.000000 36,926 20 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +22,070 $0.000000 22,070 20 Dec 2024 Common Stock 22,070 $1.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") grant, which was approved by the compensation committee of the issuer's board of directors, subject to board approval, which was obtained on November 20, 2024. Each RSU represents a contingent right to receive one share of the issuer's Class A common stock. The RSUs vest in four equal installments on February 8, 2025, May 8, 2025, August 8, 2025 and the earlier of November 8, 2025 and the date of the issuer's 2025 annual shareholders' meeting.
F2 The options vest in three equal installments on December 20, 2024, December 20, 2025 and December 20, 2026.